Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: sargramostim|BIOLOGICAL: therapeutic autologous dendritic cells|BIOLOGICAL: trastuzumab|DRUG: vinorelbine ditartrate
Sponsor: UNC Lineberger Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)|Susan G. Komen Breast Cancer Foundation